Product Reports Resources Pricing Login Book a demo

MEDICANNX

Biotech & Life Sciences · Tirat Karmel, Israel · Founded 2020

MedicannX specializes in growing high-quality medical cannabis in Israel using advanced aeroponic cultivation techniques MoreLess

MedicannX is a pioneering company in the medical cannabis industry, based in Israel, committed to producing premium-grade medical cannabis through cutting-edge aeroponic cultivation methods. Leveraging advanced technology, MedicannX utilizes a sophisticated aeroponic system that nurtures plants in a nutrient-rich mist environment, allowing for optimal growth conditions and higher yields. This innovative approach ensures superior quality and potency of cannabis, meeting the rigorous standards of the medical community. With a focus on research, development, and adherence to strict regulatory requirements, MedicannX aims to provide patients with safe, effective, and reliable medical cannabis solutions, contributing to advancements in therapeutic applications and enhancing patient care.

Company overview

MEDICANNX company information

The essential company record, classifications and operating signals in one place.

Status
Operational
Founded
2020
Headquarters
Tirat Karmel, Israel
Employees
7
Open positions
None listed
Dealroom signal
76.5
client focusb2bclient focusb2csub industryPharmaceuticalsub industryBioTechnologysectorAlternative Medicinebusiness modelManufacturingindustryHealthsectorBiotechnologysectorCannabissectorBiotech and PharmasectorMedicinal CannabissectorDT and LSsectorscience-based

Valuation & funding

MEDICANNX funding history

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
EARLY VCEquity / VC Jul 2024 $18M $74M Darwin German Real Estate Investments
Showing 1 recorded eventsUnlock the complete deal history →

Financials

Workforce over time

Available workforce history. Financial fields without reported data are omitted.

YearEmployees
2026 7
2025 7
2024 6
Company filings, research estimates and Dealroom dataOpen the full financial model →

Growth signals

MEDICANNX website traffic

Latest recorded traffic for MEDICANNX is 470 monthly website visits, up 20.5% over the last three months. MEDICANNX's team grew 0% over the past year.

Latest monthly visits470 3-month web change+20.5% 1-year team growth0%
Monthly website visits14 observations · Jul 2024–Mar 2026
Hover or focus a point to see its exact monthly valueCompare with peers →

Comparisons

MEDICANNX compared with similar companies

Dealroom’s weighted taxonomy model identifies the closest operating peers. Company identity and context stay open; selected comparison metrics preview what is available in the platform.

Showing 8 of the closest matchesCompare every metric →

Talent graph

MEDICANNX's talent

Book a demo to see the people
Team profiled 2 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 1 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Investors

1 investor on MEDICANNX's cap table

Sourced from Dealroom's funding and investor records.

Series A 1 investor entered at this stage
Darwin German Real Estate Investments

Global footprint

Where MEDICANNX has talent and traffic

Workforce by country
1 countries with
team presence
🇮🇱 Israel60%
1 country shown

In the news

Latest news about MEDICANNX

Recent press, funding announcements, and product moves mentioning MEDICANNX — open to read from the original sources.

See all news

Market sentiment

What the market is saying about MEDICANNX

An AI-synthesized read of the highest-engagement posts about MEDICANNX on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See MEDICANNX’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.